Matches in SemOpenAlex for { <https://semopenalex.org/work/W2406539966> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- W2406539966 endingPage "34" @default.
- W2406539966 startingPage "1119" @default.
- W2406539966 abstract "The effects of internal treatment were compared with those of surgical procedures on secondary hyperparathyroidism as a complication of chronic renal failure patients in order to study their applications and problems. Maintenance hemodialysis patients complicated with 2HPT were selected as test subjects. The following internal treatment was administered. 1) Elcitonine to 6 cases and 2) Ipriflavon to 5 cases respectively and applied 3) pulse therapy of 1.25(OH)2D3 to 12 cases. On the other hand, total parathyroidectomy and autotransplantation were carried out as surgical procedures. The results of the treatment were evaluated by comparing serological data including tartrate resistant acid phosphatase (TAP) measured with the passage of time, bone scintigram findings, and change of bone mineral content (BMC) measured by single photon absorptiometry and dual photon absorptiometry. In the pulse therapy group, an oral tolerance test of 6 micrograms of 1.25(OH)2D3 was carried out to investigate its relation to long term prognosis. Furthermore, in both the pulse therapy group and PTX group, serum aluminum (A1) and delta A1 calculated by Defferoxamine (DFO) tolerance test were measured. The results are as follows. 1) In Elcitonine and Ipriflavon administration groups, increase of ALP and PTH and decrease of BMC (p less than 0.05) were recognized. 2) In the pulse therapy group, although the patients with PTH-C less than 30 ng/ml showed decrease in PTH both in short and long terms, cases with PTH-C more than 30 ng/ml kept the same level in PTH. Regardless of the change of PTH and ALP, there was no significant change observed in BMC. 3) In the PTX group, ALP/TAP ratio rose by 900% temporarily and BMC increased (p less than 0.01) in all regions measured. 4) Serum A1 and delta A1 were decreased (p less than 0.01) in PTX cases and in the pulse therapy cases in which ALP was decreased. In recent years, internal treatments on 2HPT patients have become diversified. However, exacerbation of 2HPT considered as an escape phenomenon caused the decrease in BMC after exclusive calcitonine preparatives administration. Pulse therapy, which is regarded at present as most effective in reducing PTH, ALP, did not work to increase BMC efficiently. In other word, in order to attain efficient BMC increase action, it is necessary to transfer from bone resorption phase to formative phase rapidly with drastic decrease of PTH and TAP observed in PTX.(ABSTRACT TRUNCATED AT 400 WORDS)" @default.
- W2406539966 created "2016-06-24" @default.
- W2406539966 creator A5090166481 @default.
- W2406539966 date "1991-11-01" @default.
- W2406539966 modified "2023-09-25" @default.
- W2406539966 title "[Research on the treatment of secondary hyperparathyroidism as a complication of chronic renal failure]." @default.
- W2406539966 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1808363" @default.
- W2406539966 hasPublicationYear "1991" @default.
- W2406539966 type Work @default.
- W2406539966 sameAs 2406539966 @default.
- W2406539966 citedByCount "0" @default.
- W2406539966 crossrefType "journal-article" @default.
- W2406539966 hasAuthorship W2406539966A5090166481 @default.
- W2406539966 hasConcept C126322002 @default.
- W2406539966 hasConcept C126894567 @default.
- W2406539966 hasConcept C141071460 @default.
- W2406539966 hasConcept C2775945674 @default.
- W2406539966 hasConcept C2778063415 @default.
- W2406539966 hasConcept C2778122501 @default.
- W2406539966 hasConcept C2778838027 @default.
- W2406539966 hasConcept C2781208988 @default.
- W2406539966 hasConcept C2911091166 @default.
- W2406539966 hasConcept C2993356106 @default.
- W2406539966 hasConcept C519063684 @default.
- W2406539966 hasConcept C71924100 @default.
- W2406539966 hasConcept C81182388 @default.
- W2406539966 hasConcept C90924648 @default.
- W2406539966 hasConceptScore W2406539966C126322002 @default.
- W2406539966 hasConceptScore W2406539966C126894567 @default.
- W2406539966 hasConceptScore W2406539966C141071460 @default.
- W2406539966 hasConceptScore W2406539966C2775945674 @default.
- W2406539966 hasConceptScore W2406539966C2778063415 @default.
- W2406539966 hasConceptScore W2406539966C2778122501 @default.
- W2406539966 hasConceptScore W2406539966C2778838027 @default.
- W2406539966 hasConceptScore W2406539966C2781208988 @default.
- W2406539966 hasConceptScore W2406539966C2911091166 @default.
- W2406539966 hasConceptScore W2406539966C2993356106 @default.
- W2406539966 hasConceptScore W2406539966C519063684 @default.
- W2406539966 hasConceptScore W2406539966C71924100 @default.
- W2406539966 hasConceptScore W2406539966C81182388 @default.
- W2406539966 hasConceptScore W2406539966C90924648 @default.
- W2406539966 hasIssue "11" @default.
- W2406539966 hasLocation W24065399661 @default.
- W2406539966 hasOpenAccess W2406539966 @default.
- W2406539966 hasPrimaryLocation W24065399661 @default.
- W2406539966 hasRelatedWork W2008452334 @default.
- W2406539966 hasRelatedWork W2013152947 @default.
- W2406539966 hasRelatedWork W2040617300 @default.
- W2406539966 hasRelatedWork W2079008891 @default.
- W2406539966 hasRelatedWork W2146992350 @default.
- W2406539966 hasRelatedWork W2147487489 @default.
- W2406539966 hasRelatedWork W2286959862 @default.
- W2406539966 hasRelatedWork W2357537086 @default.
- W2406539966 hasRelatedWork W2404459636 @default.
- W2406539966 hasRelatedWork W2909481307 @default.
- W2406539966 hasVolume "33" @default.
- W2406539966 isParatext "false" @default.
- W2406539966 isRetracted "false" @default.
- W2406539966 magId "2406539966" @default.
- W2406539966 workType "article" @default.